Connection
Kathleen Packard to Treatment Outcome
This is a "connection" page, showing publications Kathleen Packard has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.117 |
|
|
|
-
Packard KA, Hilleman DE. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin. Cardiovasc Ther. 2016 Dec; 34(6):415-422.
Score: 0.049
-
Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest. 2004 Feb; 125(2):435-8.
Score: 0.020
-
Hilleman DE, Reyes AP, Mooss AN, Packard KA. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin. 2003; 19(5):376-82.
Score: 0.019
-
Teply RM, Packard KA, White ND, Hilleman DE, DiNicolantonio JJ. Treatment of Depression in Patients with Concomitant Cardiac Disease. Prog Cardiovasc Dis. 2016 Mar-Apr; 58(5):514-28.
Score: 0.011
-
Ling H, Packard KA, Burns TL, Hilleman DE. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris. Am J Cardiovasc Drugs. 2013 Dec; 13(6):407-12.
Score: 0.010
-
Davis EM, Packard KA, Knezevich JT, Campbell JA. New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome. Pharmacotherapy. 2011 Oct; 31(10):975-1016.
Score: 0.009